Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mirabegron Add-on Therapy with Antimuscarinics in OAB
NCT02294396Phase 4Completed
- Sponsor
- Astellas Pharma
- Start
- Oct 2014
- Primary completion
- Sep 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of mirabegron in overactive bladder (OAB), sponsored by Astellas Pharma. Started Oct 2014; status: completed.
02
Drugs
mirabegron
03
Conditions
overactive bladder (OAB)
Beyond the preview
Go deeper on NCT02294396.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02294396.